In contrast, JAK2 inhibitor AG490 can downregulate the expression of GRAMD1B in breast cancer MDA-MB-231 cells, suggesting that JAK/STAT signaling controls the expression of GRAMD1B in breast cancer cells [136]. Here, GRAMD1B is linked to breast carcinoma.